In large multi-institution retrospective studies, Ki-67, HER-2, EGFR, and N-cadherin were independent prognostic factors for bladder cancer recurrence after RNU and could be used as markers for intravesical therapies and bladder surveillance. Here, ERBB2 is linked to urinary bladder carcinoma.